Table 1 Yearly rates, rate ratios and reductions 2020–2021 vs. 2016–2019 in children < 18 years old
Mean yearly rate | Yearly rate | Rate Ratio | Reduction | |
|---|---|---|---|---|
Feb 2016-Jan 2020 | Feb 2020-Jan 2021 | |||
Visitsa | ||||
Overall clinic visits | 4852.1 ± 99.4 | 3804.1 | 0.784 (0.783 to 0.786) | 21.6% |
Respiratory visits | 1938.3 ± 85.6 | 970.7 | 0.501 (0.499 to 0.503) | 49.9% |
URI | 1459.4 ± 64.5 | 730.7 | 0.501 (0.499 to 0.504) | 49.9% |
LRI | 158.3 ± 6.2 | 66.3 | 0.419 (0.413 to 0.426) | 58.1% |
AOM | 281 ± 14.6 | 149.6 | 0.533 (0.528 to 0.539) | 46.7% |
Asthma | 39.5 ± 2.2 | 24 | 0.608 (0.592 to 0.625) | 39.2% |
AGE visits | 201.2 ± 11.3 | 106 | 0.527 (0.521 to 0.534) | 47.3% |
Non-respiratory, non-AGE visits | 540.7 ± 19.9 | 381.5 | 0.706 (0.701 to 0.711) | 29.4% |
UTI | 23.1 ± 0.9 | 18.9 | 0.818 (0.792 to 0.843) | 18.2% |
Epilepsy | 15.8 ± 0.9 | 17.1 | 1.082 (1.046 to 1.119) | -8.2% |
Trauma | 242.1 ± 8.9 | 193.9 | 0.801 (0.794 to 0.809) | 19.9% |
SSTI | 57.5 ± 1.4 | 45 | 0.782 (0.766 to 0.798) | 21.8% |
Prescriptionsa | ||||
All respiratory prescriptions | 1577.1 ± 93.5 | 838.1 | 0.532 (0.53 to 0.535) | 46.8% |
Respiratory antibiotics prescriptions | 766.4 ± 53.7 | 387.8 | 0.507 (0.504 to 0.51) | 49.3% |
Amoxicillin/Amoxicillin clavulanate | 629 ± 44.3 | 316.6 | 0.504 (0.5 to 0.508) | 49.6% |
Azithromycin | 126.1 ± 7.8 | 66.1 | 0.525 (0.517 to 0.533) | 47.5% |
Ceftriaxone | 11.3 ± 1.6 | 5.1 | 0.455 (0.429 to 0.482) | 54.5% |
Respiratory non-antibiotic prescriptions | 810.8 ± 40.6 | 450.3 | 0.556 (0.553 to 0.56) | 44.4% |
Asthma inhalators and solutions | 270.7 ± 6.2 | 164.8 | 0.609 (0.603 to 0.615) | 39.1% |
Throat relief and nasal congestion | 540.1 ± 37.1 | 285.5 | 0.53 (0.525 to 0.534) | 47.0% |
All non-respiratory prescriptions | 118.6 ± 3.6 | 110.1 | 0.928 (0.916 to 0.94) | 7.2% |
Non-respiratory antibiotics prescriptions | 56.1 ± 3 | 47.7 | 0.849 (0.832 to 0.866) | 15.1% |
OFGC | 47.5 ± 3.2 | 41.7 | 0.876 (0.858 to 0.895) | 12.4% |
TMP/SMX | 8.6 ± 0.8 | 6 | 0.697 (0.66 to 0.736) | 30.3% |
Non-respiratory, non-antibiotics prescriptions | ||||
Anti-epileptic | 62.5 ± 1 | 62.4 | 0.998 (0.981 to 1.016) | 0.2% |